Chapter/Section Purchase

1 Study Coverage
1.1 Noninvasive Prenatal Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Noninvasive Prenatal Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Noninvasive Prenatal Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Noninvasive Prenatal Diagnostics Market Size for the Year 2017-2028
1.3 Noninvasive Prenatal Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Noninvasive Prenatal Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Noninvasive Prenatal Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Noninvasive Prenatal Diagnostics Market Dynamics
1.4.1 Noninvasive Prenatal Diagnostics Industry Trends
1.4.2 Noninvasive Prenatal Diagnostics Market Drivers
1.4.3 Noninvasive Prenatal Diagnostics Market Challenges
1.4.4 Noninvasive Prenatal Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Noninvasive Prenatal Diagnostics by Type
2.1 Noninvasive Prenatal Diagnostics Market Segment by Type
2.1.1 Services
2.1.2 Instrument
2.2 Global Noninvasive Prenatal Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028)
2.4 United States Noninvasive Prenatal Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028)
3 Noninvasive Prenatal Diagnostics by Application
3.1 Noninvasive Prenatal Diagnostics Market Segment by Application
3.1.1 Hospital
3.1.2 Personal
3.1.3 Other
3.2 Global Noninvasive Prenatal Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028)
3.4 United States Noninvasive Prenatal Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028)
4 Global Noninvasive Prenatal Diagnostics Competitor Landscape by Company
4.1 Global Noninvasive Prenatal Diagnostics Market Size by Company
4.1.1 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Noninvasive Prenatal Diagnostics Revenue by Player (2017-2022)
4.2 Global Noninvasive Prenatal Diagnostics Concentration Ratio (CR)
4.2.1 Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Noninvasive Prenatal Diagnostics in 2021
4.2.3 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Noninvasive Prenatal Diagnostics Headquarters, Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Noninvasive Prenatal Diagnostics Headquarters and Area Served
4.3.2 Global Noninvasive Prenatal Diagnostics Companies Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Noninvasive Prenatal Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Noninvasive Prenatal Diagnostics Market Size by Company
4.5.1 Top Noninvasive Prenatal Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Noninvasive Prenatal Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Noninvasive Prenatal Diagnostics Market Size by Region
5.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Noninvasive Prenatal Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Noninvasive Prenatal Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Natera
7.1.1 Natera Company Details
7.1.2 Natera Business Overview
7.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
7.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.1.5 Natera Recent Development
7.2 Illumina
7.2.1 Illumina Company Details
7.2.2 Illumina Business Overview
7.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
7.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.2.5 Illumina Recent Development
7.3 BGI Diagnosis
7.3.1 BGI Diagnosis Company Details
7.3.2 BGI Diagnosis Business Overview
7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
7.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.3.5 BGI Diagnosis Recent Development
7.4 Ariosa Diagnostics
7.4.1 Ariosa Diagnostics Company Details
7.4.2 Ariosa Diagnostics Business Overview
7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.4.5 Ariosa Diagnostics Recent Development
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Company Details
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.5.5 Quest Diagnostics Recent Development
7.6 Premaitha Health
7.6.1 Premaitha Health Company Details
7.6.2 Premaitha Health Business Overview
7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
7.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.6.5 Premaitha Health Recent Development
7.7 NIPD Genetics
7.7.1 NIPD Genetics Company Details
7.7.2 NIPD Genetics Business Overview
7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
7.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.7.5 NIPD Genetics Recent Development
7.8 Labcorp
7.8.1 Labcorp Company Details
7.8.2 Labcorp Business Overview
7.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
7.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.8.5 Labcorp Recent Development
7.9 Ravgen
7.9.1 Ravgen Company Details
7.9.2 Ravgen Business Overview
7.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
7.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.9.5 Ravgen Recent Development
7.10 LifeCodexx
7.10.1 LifeCodexx Company Details
7.10.2 LifeCodexx Business Overview
7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
7.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.10.5 LifeCodexx Recent Development
7.11 TrovaGene
7.11.1 TrovaGene Company Details
7.11.2 TrovaGene Business Overview
7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
7.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.11.5 TrovaGene Recent Development
7.12 Quest Diagnostics
7.12.1 Quest Diagnostics Company Details
7.12.2 Quest Diagnostics Business Overview
7.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.12.5 Quest Diagnostics Recent Development
7.13 Berry Genomics
7.13.1 Berry Genomics Company Details
7.13.2 Berry Genomics Business Overview
7.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
7.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.13.5 Berry Genomics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer